Literature DB >> 6531081

Magnetic resonance tomography (MRT) of intracranial tumours: initial experience with the use of the contrast medium Gadolinium-DTPA.

W Schörner, E Kazner, M Laniado, C Sprung, R Felix.   

Abstract

The present study provides an introduction to the clinical diagnosis of intracranial lesions by means of magnetic resonance tomography (MRT). The demonstration of different tissue qualities (bone and bone marrow, cerebral cortex and medulla, ventricular system (CSF), blood, tumour and perifocal oedema) in the MR tomogram is explained. The principles of specific MRT contrast media and their clinical application in brain tumours are discussed in detail.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6531081     DOI： 10.1007/bf01892910

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   3.042


  15 in total

1.  Imaging of the brain by nuclear magnetic resonance.

Authors:  F H Doyle; J C Gore; J M Pennock; G M Bydder; J S Orr; R E Steiner; I R Young; M Burl; H Clow; D J Gilderdale; D R Bailes; P E Walters
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

2.  [Human testing of the nuclear spin tomographic contrast medium gadolinium-DTPA. Tolerance, contrast affect and the 1st clinical results].

Authors:  W Schörner; R Felix; M Laniado; L Lange; H J Weinmann; C Claussen; W Fiegler; U Speck; E Kazner
Journal:  Rofo       Date:  1984-05

3.  Nuclear magnetic resonance imaging of the brain in multiple sclerosis.

Authors:  I R Young; A S Hall; C A Pallis; N J Legg; G M Bydder; R E Steiner
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

4.  Clinical NMR imaging of the brain: 140 cases.

Authors:  G M Bydder; R E Steiner; I R Young; A S Hall; D J Thomas; J Marshall; C A Pallis; N J Legg
Journal:  AJR Am J Roentgenol       Date:  1982-08       Impact factor: 3.959

5.  Primary intracranial tumor imaging: a comparison of magnetic resonance and CT.

Authors:  M Brant-Zawadzki; J P Badami; C M Mills; D Norman; T H Newton
Journal:  Radiology       Date:  1984-02       Impact factor: 11.105

6.  Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

Authors:  H J Weinmann; R C Brasch; W R Press; G E Wesbey
Journal:  AJR Am J Roentgenol       Date:  1984-03       Impact factor: 3.959

7.  Clinical NMR imaging of the brain in children: normal and neurologic disease.

Authors:  M A Johnson; J M Pennock; G M Bydder; R E Steiner; D J Thomas; R Hayward; D R Bryant; J A Payne; M I Levene; A Whitelaw
Journal:  AJR Am J Roentgenol       Date:  1983-11       Impact factor: 3.959

8.  Cerebral abnormalities: use of calculated T1 and T2 magnetic resonance images for diagnosis.

Authors:  C M Mills; L E Crooks; L Kaufman; M Brant-Zawadzki
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

9.  Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumors.

Authors:  C Claussen; M Laniado; E Kazner; W Schörner; R Felix
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

10.  Tumor detection by nuclear magnetic resonance.

Authors:  R Damadian
Journal:  Science       Date:  1971-03-19       Impact factor: 47.728
View more
  2 in total

1.  The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.

Authors:  T Nakamura; W Schörner; R C Bittner; R Felix
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

Review 2.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Authors:  Jessica Lohrke; Thomas Frenzel; Jan Endrikat; Filipe Caseiro Alves; Thomas M Grist; Meng Law; Jeong Min Lee; Tim Leiner; Kun-Cheng Li; Konstantin Nikolaou; Martin R Prince; Hans H Schild; Jeffrey C Weinreb; Kohki Yoshikawa; Hubertus Pietsch
Journal:  Adv Ther       Date:  2016-01-25       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.